Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00p -1.50% 65.80p 172,044 16:35:01
Bid Price Offer Price High Price Low Price Open Price
65.40p 66.60p 68.00p 65.40p 67.80p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 103.32 28.37 6.10 10.8 339.0

Alliance Pharma (APH) Latest News

More Alliance Pharma News
Alliance Pharma Takeover Rumours

Alliance Pharma (APH) Share Charts

1 Year Alliance Pharma Chart

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

1 Month Alliance Pharma Chart

Intraday Alliance Pharma Chart

Intraday Alliance Pharma Chart

Alliance Pharma (APH) Discussions and Chat

Alliance Pharma Forums and Chat

Date Time Title Posts
11/12/201809:08Alliance Pharma pays Dividends1,286
21/8/201816:36A Canadian Stock Worth Watching1
07/11/201615:35Alliance Pharma plc1
15/7/201309:15ALLIANCE PHARMA – 2005 Strong Riser611

Add a New Thread

Alliance Pharma (APH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-12-11 17:06:0865.80855562.56O
2018-12-11 16:51:0266.346,6334,400.28O
2018-12-11 16:50:5067.803,7392,535.04O
2018-12-11 16:35:0165.804,6123,034.70UT
2018-12-11 16:28:5765.40404264.22AT
View all Alliance Pharma trades in real-time

Alliance Pharma (APH) Top Chat Posts

Alliance Pharma Daily Update: Alliance Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 66.80p.
Alliance Pharma has a 4 week average price of 60p and a 12 week average price of 60p.
The 1 year high share price is 102.50p while the 1 year low share price is currently 58p.
There are currently 515,127,294 shares in issue and the average daily traded volume is 1,262,034 shares. The market capitalisation of Alliance Pharma is £338,953,759.45.
markdallara: JD needs the money for some purpose now. He knew he was going to need it but didn't sell earlier because like the rest of us he was expecting further share price growth.
winnings1: I do not think it likely that the share price will go down much further from where it is just now (62p), indeed I think it likely that we may see a rise to region 70p-75p over the coming weeks, assuming the global stock markets are to stabilize.
winnings1: One Director selling a smallish portion of his large holding does not amount to the Board selling out. We need to remember that Directors have a home to keep up or a new larger home to move into, a family to look after, school fees to pay etc., so nothing ominous about a Director s selling a portion of his shares to raise cash for his needs. The share price today is much below where it should be. The fundamentals are sound and solid and point in the direction of 80p+ as fair value. The markets in general are wobbly and much of that is to be blamed on Trump and his threats of trade wars. Nobody benefits form trade wars, least of all the American consumers who will have to pay more for their imported goods. America can not compete with China on prices, not even by doubling or trebling import levies. The only ways to compete with China on prices is to decimate US labour costs. Try that one Trump!
winnings1: Dround87 - If earnings were rising fast then the share price would be region 150p. Defensive stock because of steady rising earnings in a continuing (permanent) growth market (medicines).
winnings1: I consider APH a defensive stock, the share price may wobble a little but won't crash in these turbulent times, indeed may even rise when markets are in sharp falls. I hold long term.
cisk: Livingbridge aren’t even a major shareholder, there has been no RNS re their holding, I don’t think they were even over 3% and I’m sorry I’m not going to sit through their webinar to find out what they said. For those that are concerned, take a look at Livingbridge’s top 10 holdings - nothing much to write home about. And they mirror their benchmark and I wouldn’t say their performance is spectacular. So I just don’t see the performance of an average fund impacting the share price to that extent. So personally I care not a jot what this fund does. I do care about upcoming launches and the pending good news flow coming from the company, and Nizoral sales getting going and feeding through to the bottom line. Really the share price got ahead of itself this year, it’s probably oversold now but it’s an opportunity to top up, if you feel like doing so in the current market. Alliance has grown steadily, and through deals etc it’s not as reliant on a single product as it once was.
winnings1: Remarkable how low the share price of APH has gone (65p-66p today). In the current uncertain times (political and financial) the shares of APH should be at a premium as the Company operates in recession proof territory, Demand for medicines will continue to go up, whatever the state of the global economy.
tryone2: Perhaps it’s time to look why the sudden drop in share price since July ?
winnings1: Nice Article in The Times about APH's newly licensed anti-sickness drug, should bode b well for a good start with sales. Share price, already up nicely, should harden from hereon.
arf dysg: I notice that the International Misery Fund said that we're screwed, blued and tattooed. Putting it in slightly more formal language, the predictions for growth in the USA and the UK have gone down a little. Perhaps that's why everyone's taking drugs as if there's no tomorrow, so the APH share price has gone up.
Alliance Pharma share price data is direct from the London Stock Exchange
Your Recent History
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181212 00:30:39